Citation Impact
Citing Papers
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody
2010
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature
Hypoxia — a key regulatory factor in tumour growth
2002 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease
2005
PROGNOSTIC FACTORS IN MULTIPLE MYELOMA
1999
Myeloid-derived suppressor cells coming of age
2018 Standout
Circulating immune cell phenotype can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma
2016
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial
2003 Standout
Integrated care prevents hospitalisations for exacerbations in COPD patients
2006 Standout
Determinants of Depression in the ECLIPSE Chronic Obstructive Pulmonary Disease Cohort
2010
Hyperinflation, Dyspnea, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease
2006
Efficacy and Tolerability of Budesonide/Formoterol Added to Tiotropium in Patients with Chronic Obstructive Pulmonary Disease
2009
Epidemiology of COPD
2009 Standout
The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review
2010 Standout
The association of depression and anxiety with medical symptom burden in patients with chronic medical illness
2007
Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs
2017
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD
2008
COPD exacerbations {middle dot} 5: Management
2006
Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma
2017
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
COPD and the Risk of Depression
2009
Linking “big” personality traits to anxiety, depressive, and substance use disorders: A meta-analysis.
2010 Standout
Asthma
2017 Standout
The biological and clinical significance of the KI‐67 growth fraction in multiple myeloma
1992
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
Prevalence and correlates of DSM-IV major depression in an Australian national survey
2002
The global burden of multiple chronic conditions: A narrative review
2018 Standout
Interpretative strategies for lung function tests
2005 Standout
Anxiety and Depression are Related to the Outcome of Emergency Treatment in Patients with Obstructive Pulmonary Disease
2002
Systemic amyloidosis
2015 Standout
Management of disease-related anemia in patients with multiple myeloma or chronic lymphocytic leukemia: epoetin treatment recommendations
2002
The impact of hemoglobin levels on treatment outcomes in patients with cancer
2001
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels
2014 Standout
Prevalence and predictors of depression in populations of elderly: a review
2006 Standout
Mild Traumatic Brain Injury in U.S. Soldiers Returning from Iraq
2008 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
2003 Standout
The Long-Term Health Consequences of Child Physical Abuse, Emotional Abuse, and Neglect: A Systematic Review and Meta-Analysis
2012 Standout
Applications of machine learning in drug discovery and development
2019 Standout
The Ki-67 protein: From the known and the unknown
2000 Standout
Psychological assessment of patients with Menière's disease
2006
Mechanisms of Bone Metastasis
2004 Standout
Lung disease and internalizing disorders
2003
Lymphoid subsets in acute myeloid leukemias: Increased number of cells with NK phenotype and normal T-cell distribution
1993
Global burden of COPD: risk factors, prevalence, and future trends
2007 Standout
An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab
2003
Women manifest more severe COPD symptoms across the life course
2018
Differences in COPD Exacerbation Risk Between Women and Men
2019
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Inspiratory-to-Total Lung Capacity Ratio Predicts Mortality in Patients with Chronic Obstructive Pulmonary Disease
2005
The Role of Selenium in Inflammation and Immunity: From Molecular Mechanisms to Therapeutic Opportunities
2011 Standout
Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell–mediated tumor responses
2022 StandoutNobel
The Epidemiology of Depression Across Cultures
2013 Standout
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Twelve‐month prevalence, comorbidity and correlates of mental disorders in Germany: the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1‐MH)
2014 Standout
The Origins of Health and Disease
2011
Circulating Ki67 positive lymphocytes in multiple myeloma and benign monoclonal gammopathy.
1995
The etiologies, pathophysiology, and alternative/complementary treatment of asthma.
2001
Increasing awareness of sex differences in airway diseases
2015
The emerging role of immune checkpoint based approaches in AML and MDS
2017 StandoutNobel
Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease
2003
A network theory of mental disorders
2017 Standout
Impact of allergy treatment on the association between allergies and mood and anxiety in a population sample
2012
The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003
2003 Standout
Anxiety and Depression in COPD
2008
Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14)
2011
Strategies for Combining Immunotherapy with Radiation for Anticancer Therapy
2015 StandoutNobel
Network Analysis: An Integrative Approach to the Structure of Psychopathology
2013 Standout
Multiple Myeloma
2011 Standout
A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma
2012
International Staging System for Multiple Myeloma
2005 Standout
Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib
2006
Works of F. Casanova being referenced
Bronchodilating effect of oxitropium bromide in heart disease patients with exacerbations of COPD: double-blind, randomized, controlled study
2002
Anxiety and depression in COPD patients: The roles of gender and disease severity
2006
Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD
2002
Psychological issues in the treatment of asthmatic patients
2000
Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease
1991
Prognostic implications of DNA aneuploidy in 156 untreated multiple myeloma patients
1995
Lymphoid subsets and prognostic factors in multiple myeloma
1992
Analysis of natural killer‐associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implications
1996
A new staging system for multiple myeloma based on the number of S- phase plasma cells
1995
A new staging system for multiple myeloma based on the number of S- phase plasma cells
1995
Increased expression of natural‐killer‐associated and activation antigens in multiple myeloma
1992